Jean N. Bastie
Dijon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.
Journal: British journal of haematology
Published: May 15, 2026
High Fluorescent Lymphoid Cell Levels Assessed on Initial Blood Count in Newly Diagnosed Multiple Myeloma Carry Prognostic Significance.
Journal: EJHaem
Published: October 16, 2024
Clinical and Economic Impact of a Multidisciplinary Follow-Up Program in Lymphoma Patients.
Journal: Cancers
Published: April 24, 2022
Oxaliplatin-Induced Evans Syndrome: A Possible Dual Mechanism.
Journal: Clinical colorectal cancer
Published: April 15, 2019
HSP27 is a partner of JAK2-STAT5 and a potential therapeutic target in myelofibrosis.
Journal: Nature communications
Published: February 10, 2017
A randomized phase II trial of azacitidine +/- epoetin-β in lower-risk myelodysplastic syndromes resistant to erythropoietic stimulating agents.
Journal: Haematologica
Published: December 21, 2015
Evolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.
Journal: Mycoses
Published: October 10, 2015
De-escalation chemotherapy and hematological profiles in patients with advanced Hodgkin's lymphoma.
Journal: International journal of clinical pharmacy
Published: February 25, 2015
Detection of the CALR mutation in the diagnosis of splanchnic vein thrombosis.
Journal: British journal of haematology
Published: November 22, 2014
Perforation of bowel lymphoma: beware of atypical presentations.
Journal: Journal of gastrointestinal cancer
Published: February 04, 2014
Showing 1-11 of 11
Last Updated: 09/26/2026